Dental Literature Watch · Consensus · Oral Surgery
Chlorhexidine, confirmed — and a combination that patients will actually finish
TL;DR
- Chlorhexidine 0.12-0.2% is confirmed as the reference perioperative antiseptic for dentoalveolar and implant surgery — RR 0.66 (95% CI 0.55-0.80) for postoperative complications across 69 included studies.
- The genuinely new recommendation is the combination. The panel recommends CHX + CPC formulations (e.g. 0.12% CHX + 0.05% cetylpyridinium chloride) as an alternative: comparable antimicrobial efficacy, better tolerability than CHX alone.
- Postoperative care is risk-stratified, not one-size — gel, rinse and spray formulations matched to the patient profile.
- Povidone-iodine and CPC are named as evidence-supported alternatives when chlorhexidine is not usable.
- Complication-specific pathways for wound dehiscence, alveolar osteitis and localised postoperative infection, escalating from antiseptic irrigation and intra-alveolar gel to surgery and systemic antibiotics by severity.
- Every recommendation is labelled as evidence-based, expert-consensus-derived, or both. The labels are uneven on purpose — the panel is telling you which lines to lean on.
What changed
| Question | Recommendation |
|---|---|
| Reference perioperative antiseptic | CHX 0.12-0.2%, alone or combined with CPC — RR 0.66 (0.55-0.80) for postoperative complications |
| When CHX is poorly tolerated | 0.12% CHX + 0.05% CPC — comparable efficacy, improved tolerability |
| Other alternatives | Povidone-iodine and CPC, both evidence-supported |
| Postoperative protocol | Risk-stratified: gel / rinse / spray chosen by procedural complexity, comorbidity and tolerability |
| Wound dehiscence · alveolar osteitis · local infection | Graded pathway from antiseptic irrigation and intra-alveolar gel up to surgical and systemic antibiotic management |
| Evidence labelling | Each recommendation flagged evidence-based, consensus-derived, or a combination |
RR 0.66 is a real effect size, and it is the anchor of the document
A third fewer postoperative complications is the kind of number that survives being quoted to a sceptical colleague.
Notice what it is attached to: perioperative chlorhexidine, which most practices already stock. The finding is not a new product — it is that the protocol around an old one has never been standardised.
A third fewer postoperative complications is the kind of number that survives being quoted to a sceptical colleague.
Notice what it is attached to: perioperative chlorhexidine, which most practices already stock. The finding is not a new product — it is that the protocol around an old one has never been standardised.
💎 Insight — what this means chairside
The CHX + CPC combination is the line to act on
Chlorhexidine's problem was never efficacy — it was staining, taste disturbance and patients quietly stopping on day three.
A combination that matches its antimicrobial performance with better tolerability turns a compliance problem into a product-selection decision.
If your postop instruction sheet says "0.12% chlorhexidine rinse" and nothing else, this is the document that justifies revising it.
Chlorhexidine's problem was never efficacy — it was staining, taste disturbance and patients quietly stopping on day three.
A combination that matches its antimicrobial performance with better tolerability turns a compliance problem into a product-selection decision.
If your postop instruction sheet says "0.12% chlorhexidine rinse" and nothing else, this is the document that justifies revising it.
Formulation is a variable you probably were not using
The panel treats gel, rinse and spray as clinically distinct choices matched to the patient, not as packaging.
Intra-alveolar gel in particular shows up in the alveolar-osteitis pathway — a socket that will not be reached by a rinse.
The panel treats gel, rinse and spray as clinically distinct choices matched to the patient, not as packaging.
Intra-alveolar gel in particular shows up in the alveolar-osteitis pathway — a socket that will not be reached by a rinse.
Alveolar osteitis gets a graded pathway instead of a habit
Dry-socket management is one of the more folklore-driven corners of general practice.
Conservative antiseptic irrigation and gel first, escalation reserved for severity, is a defensible sequence that also keeps systemic antibiotics out of the first move.
Dry-socket management is one of the more folklore-driven corners of general practice.
Conservative antiseptic irrigation and gel first, escalation reserved for severity, is a defensible sequence that also keeps systemic antibiotics out of the first move.
Povidone-iodine is a real fallback, not a compromise
For the CHX-allergic patient, or the one who cannot tolerate the taste at all, the panel puts povidone-iodine on the evidence-supported list rather than leaving you improvising.
For the CHX-allergic patient, or the one who cannot tolerate the taste at all, the panel puts povidone-iodine on the evidence-supported list rather than leaving you improvising.
⚠️ The catch
Seven panellists from four universities, all in one country
This is a structured two-round expert consensus by seven Spanish oral surgeons and implantologists, not a multi-society international guideline.
The literature search was systematic; the recommendations on top of it are the judgement of a small, geographically narrow group. Product availability and prescribing norms differ.
This is a structured two-round expert consensus by seven Spanish oral surgeons and implantologists, not a multi-society international guideline.
The literature search was systematic; the recommendations on top of it are the judgement of a small, geographically narrow group. Product availability and prescribing norms differ.
Consensus fills in where evidence runs out, and the panel admits it
Sixty-nine studies were included in a qualitative synthesis — qualitative, not pooled, except where the RR is quoted.
The explicit evidence-based vs consensus-derived labelling exists because the quality is uneven across scenarios. The complication-specific pathways are the parts most likely resting on expert opinion.
Sixty-nine studies were included in a qualitative synthesis — qualitative, not pooled, except where the RR is quoted.
The explicit evidence-based vs consensus-derived labelling exists because the quality is uneven across scenarios. The complication-specific pathways are the parts most likely resting on expert opinion.
Written up from the structured abstract
The figures above are as published in the abstract. Nothing has been inferred or filled in.
fulltext.py found no free copy through Europe PMC, and Unpaywall could not be queried (contact email unset), so the per-scenario recommendation text and the evidence labels attached to each one were not read.The figures above are as published in the abstract. Nothing has been inferred or filled in.
The RR is for "postoperative complications" as a composite
The abstract does not break out which complications drive it.
A composite that mixes dry socket, infection and dehiscence can be moved by its most common component, which may not be the one you were worried about.
The abstract does not break out which complications drive it.
A composite that mixes dry socket, infection and dehiscence can be moved by its most common component, which may not be the one you were worried about.
⚡ Bottom line
- Routine extraction or implant placement → perioperative CHX 0.12-0.2% remains the reference. RR 0.66 for postoperative complications.
- Patient who stains, gags or quits on chlorhexidine → 0.12% CHX + 0.05% CPC, comparable efficacy and better tolerated.
- True chlorhexidine intolerance → povidone-iodine or CPC, both evidence-supported.
- Dry socket → debride and irrigate, intra-alveolar antiseptic gel; escalate to systemic antibiotics by severity, not by default.
- Writing your postop sheet → choose the formulation — gel, rinse or spray — to the case, not to the shelf.
🧪 Questions
Tap an answer — instant grade, deciding line, and the trap.
A patient returning for a third implant placement tells you the chlorhexidine rinse after the last surgery stained her teeth badly and she stopped it after four days. Per the 2026 consensus, what is the best alternative perioperative antiseptic?
The CHX + CPC combination is the panel's named alternative — comparable antimicrobial efficacy with an improved tolerability profile relative to CHX monotherapy. Saline alone abandons the RR 0.66 benefit for no gain. Halving the concentration drops below the recommended 0.12-0.2% band and is not a listed option. Systemic antibiotics substitute a systemic exposure for a topical one and are reserved in this document for escalation by severity, not for tolerability.
The consensus reports a relative risk of 0.66 (95% CI 0.55-0.80) for perioperative chlorhexidine. What is the correct reading of that figure?
RR 0.66 means the risk fell to roughly two-thirds of baseline — about a third fewer events. 66 percent reduction is the classic misread of a relative risk as a relative risk reduction. Not significant is wrong: the confidence interval, 0.55 to 0.80, excludes 1.0. Specific to alveolar osteitis overreads it — the abstract reports a composite of postoperative complications and does not break the components out, which is itself a limitation of the figure.
A patient presents on day four after a lower molar extraction with severe pain and an empty-looking socket. Following the consensus pathway, what is the first-line management?
The pathway starts conservative and escalates by severity: antiseptic irrigation and intra-alveolar gel first. Immediate systemic antibiotics jumps to the top of the ladder for a condition that is not primarily infective. Surgical debridement with closure is the escalation step, reserved for severity. Curettage to establish bleeding is a traditional manoeuvre this graded pathway does not put first — the appeal of the recommendation is exactly that it displaces habit with a sequence.